Mylan sells its 5.64% Biocon stake within six months, institutional...
Mumbai: US-based generic pharma major Mylan has sold its 5.64% share in Biocon Ltd within 6 months of getting it. The shares were allocated to it as part of an...
Mumbai: US-based generic pharma major Mylan has sold its 5.64% share in Biocon Ltd within 6 months of getting it. The shares were allocated to it as part of an...
Mumbai: India’s second-largest mutual fund house, ICICI Prudential AMC, is all set to go public with its IPO slated to open on December 12, one of the last high-profile IPOs...
Indian investors have come a long way from depending solely on ‘safe’ and dependable gold and real estate to the flexibility of equities. The Mutual Fund industry has faced immense...
New Delhi – Direct Mutual Funds officially completed ten years of existence on January 1, 2023, allowing Indian investors to earn 1% more than regular funds by saving on commissions. To...